Lonza to continue narsoplimab manufacture for Omeros 01-Aug-2019 By Vassia Barba Lonza extends its deal with Omeros for the commercial manufacture of a treatment for thrombotic microangiopathy, ahead of filing with the US FDA and the EMA.